LECOM Health

renal denervation

LECOM Health Cardiologist to Perform First in Class Groundbreaking FDA-Approved Therapy for Treatment of Resistant Hypertension

LECOM Health Cardiologist to Perform First in Class Groundbreaking FDA-Approved Therapy for Treatment of Resistant Hypertension

ERIE, Pa. (April 25, 2024) – LECOM Health is pleased to announce the treatment of the first five patients with a new renal denervation (RDN) procedure, now offered for certain patients with high blood pressure. Recently approved by the U.S. Food and Drug Administration (FDA), the Symplicity Spyral™ renal denervation (RDN) system – involves a minimally invasive procedure that targets nerves near the kidneys that can become overactive and cause high blood pressure. Matthew C. Becker, M.D., Chairman...Read More »

Looking for more information?

This is default text for notification bar